Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Context Asset Management launches with new mutual fund product

Tuesday, April 01, 2014

Bailey McCann, Opalesque New York:

Another new entrant to the liquid alternatives space - Context Asset Management has launched a new mutual fund Context Alternative Strategies Fund (CALTX), a multi-manager, multi-strategy fund. Context principals Steve Kneeley and John Culbertson have prior experience managing a fund and family office respectively. Context Asset Management is located in Pennsylvania, and aims to provide investors with access to higher quality managers than one might otherwise find in a liquid alternatives product.

"We think the quality of sub-advisors in a lot of these products isn't particularly high," Culbertson, Managing Director and Chief Investment Officer of Context, tells Opalesque. "We're created the first fund with managers that we think offer a higher level of quality. A startup fund probably isn't for us in terms of a sub-advisory relationship."

As with most multi-manager funds CALTX's aim is to provide a lower volatility, low correlation product. "We're looking at a variety of strategies, equity long/short with a long bias is one that really works well in this structure," Culbertson says. Later on the firm plans to use its pipeline of potential sub-advisors to look at funds with particular specialties.

"There are managers out there who often do one thing really well so we're looking to work with those managers and let them come in as sub-advisors focusing on what they do best," Culbertson adds.

......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its